Recurrent Nasopharyngeal Cancer
4 clinical trials · Condition
◉ Watch Recurrent Nasopharyngeal Cancer
| Record | Firm | Date |
|---|---|---|
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer (NCT00305734) | National Cancer Institute (NCI) | 2006-08-01 |
| Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas (NCT00101270) | National Cancer Institute (NCI) | 2005-03-01 |
| Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment (NCT00091182) | National Cancer Institute (NCI) | 2004-10-01 |
Track Recurrent Nasopharyngeal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.